Lee et al. found that SREBP1c overexpression promotes lipogenesis and tumor cell proliferation, and RNF20 inhibits lipogenesis and cell cycle progression in ccRCC by inhibiting the SREBP-1c pathway [49]. Here, RNF20 is linked to nonpapillary renal cell carcinoma.